Kai P Law1, Ting-Li Han2, Xun Mao3, Hua Zhang4. 1. Mass Spectrometry Centre, China-Canada-New Zealand Joint Laboratory of Maternal and Foetal Medicine, Chongqing Medical University, Chongqing, China. Electronic address: kai.law1@virginmedia.com. 2. Mass Spectrometry Centre, China-Canada-New Zealand Joint Laboratory of Maternal and Foetal Medicine, Chongqing Medical University, Chongqing, China. 3. Mass Spectrometry Centre, China-Canada-New Zealand Joint Laboratory of Maternal and Foetal Medicine, Chongqing Medical University, Chongqing, China; Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 4. Mass Spectrometry Centre, China-Canada-New Zealand Joint Laboratory of Maternal and Foetal Medicine, Chongqing Medical University, Chongqing, China; Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: zh2844@gmail.com.
Abstract
BACKGROUND: Gestational diabetes mellitus (GDM) is a pathological state of glucose intolerance associated with adverse pregnancy outcomes and an increased risk of developing maternal type 2 diabetes later in life. The mechanisms underlying GDM development are not fully understood. We examined the pathophysiology of GDM through comprehensive metabolic profiling of maternal urine, using participants from a longitudinal cohort of normal pregnancies and pregnancies complicated by GDM. METHODS: Based on ultra-performance liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry, an untargeted metabolomics study was performed to explore the differences in the urinary metabolome of GDM cases and healthy controls over the course of pregnancy. Multilevel statistical approaches were employed to address the complex metabolomic data obtained from a longitudinal cohort. RESULTS: The results indicated that tryptophan and purine metabolism was associated with GDM. The tryptophan-kynurenine pathway was activated in the GDM subjects before placental hormones or the fetoplacental unit could have produced any physiological effect. Hypoxanthine, xanthine, xanthosine, and 1-methylhypoxanthine were all elevated in the urine metabolome of subjects with GDM. Catabolism of purine nucleosides leads ultimately to the production of uric acid, which discriminated the subjects with GDM from controls. CONCLUSIONS: The results support the notion that GDM may be a predisposed condition, or prediabetic state, which is manifested during pregnancy. This challenges the conventional view of the pathogenesis of GDM, which assumes placental hormones are the major causes of insulin resistance in GDM.
BACKGROUND:Gestational diabetes mellitus (GDM) is a pathological state of glucose intolerance associated with adverse pregnancy outcomes and an increased risk of developing maternal type 2 diabetes later in life. The mechanisms underlying GDM development are not fully understood. We examined the pathophysiology of GDM through comprehensive metabolic profiling of maternal urine, using participants from a longitudinal cohort of normal pregnancies and pregnancies complicated by GDM. METHODS: Based on ultra-performance liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry, an untargeted metabolomics study was performed to explore the differences in the urinary metabolome of GDM cases and healthy controls over the course of pregnancy. Multilevel statistical approaches were employed to address the complex metabolomic data obtained from a longitudinal cohort. RESULTS: The results indicated that tryptophan and purine metabolism was associated with GDM. The tryptophan-kynurenine pathway was activated in the GDM subjects before placental hormones or the fetoplacental unit could have produced any physiological effect. Hypoxanthine, xanthine, xanthosine, and 1-methylhypoxanthine were all elevated in the urine metabolome of subjects with GDM. Catabolism of purinenucleosides leads ultimately to the production of uric acid, which discriminated the subjects with GDM from controls. CONCLUSIONS: The results support the notion that GDM may be a predisposed condition, or prediabetic state, which is manifested during pregnancy. This challenges the conventional view of the pathogenesis of GDM, which assumes placental hormones are the major causes of insulin resistance in GDM.
Authors: Jill K Morris; Brian D Piccolo; Kartik Shankar; John P Thyfault; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2017-12-26 Impact factor: 4.310
Authors: Lauren E McMichael; Hannah Heath; Catherine M Johnson; Rob Fanter; Noemi Alarcon; Adilene Quintana-Diaz; Kari Pilolla; Andrew Schaffner; Elissa Jelalian; Rena R Wing; Alex Brito; Suzanne Phelan; Michael R La Frano Journal: Metabolomics Date: 2021-11-27 Impact factor: 4.290
Authors: M F Vokuev; Т М Baygildiev; I V Plyushchenko; Y A Ikhalaynen; R L Ogorodnikov; I K Solontsov; А V Braun; E I Savelieva; I V Rуbalchenko; I A Rodin Journal: Anal Bioanal Chem Date: 2021-09-21 Impact factor: 4.142
Authors: Yeyi Zhu; Dinesh K Barupal; Amanda L Ngo; Charles P Quesenberry; Juanran Feng; Oliver Fiehn; Assiamira Ferrara Journal: Diabetes Date: 2022-08-01 Impact factor: 9.337